HL Financial Services’s Meridian Bioscience Inc VIVO Stock Holding History

HL Financial Services’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,450	Closed	-$192K	–	711
2017 Q3	$192K	Sell	13,450 -500	-4%	-$7.14K	﹤0.01%	661
2017 Q2	$220K	Hold	13,950	–	–	﹤0.01%	638
2017 Q1	$193K	Sell	13,950 -2,228	-14%	-$31.2K	﹤0.01%	641
2016 Q4	$286K	Buy	16,178 +2,364	+17%	+$41.5K	0.01%	566
2016 Q3	$266K	Sell	13,814 -46,710	-77%	-$914K	0.01%	563
2016 Q2	$1.18M	Buy	60,524 +16,805	+38%	+$330K	0.03%	297
2016 Q1	$901K	Buy	43,719 +1,926	+5%	+$38K	0.02%	324
2015 Q4	$858K	Sell	41,793 -497	-1%	-$9.53K	0.02%	338
2015 Q3	$723K	Sell	42,290 -9,920	-19%	-$181K	0.02%	337
2015 Q2	$973K	Sell	52,210 -2,762	-5%	-$51.2K	0.03%	314
2015 Q1	$1.05M	Buy	54,972 +21,060	+62%	+$389K	0.03%	279
2014 Q4	$558K	Buy	+33,912	New	+$582K	0.02%	403

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

HL Financial Services's VIVO Position: Q4 2017 in Review

HL Financial Services sold out of Meridian Bioscience Inc (VIVO) in Q4 2017, closing a stake of 13,450 shares — an estimated $192K sold.

HL Financial Services first reported a position in VIVO in Q4 2014 and held it in 12 quarters. The position peaked at $1.18M in Q2 2016. 178 funds tracked by Wall St. Rank hold VIVO as of Q4 2017.

HL Financial Services reported no remaining Meridian Bioscience Inc position as of Q4 2017 after selling out during the quarter.
HL Financial Services sold 13,450 Meridian Bioscience Inc shares in Q4 2017, an estimated $192K.
HL Financial Services first reported a position in Meridian Bioscience Inc in Q4 2014 and held it in 12 quarters.
HL Financial Services's Meridian Bioscience Inc position peaked at $1.18M in Q2 2016.
178 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2017.

Based on HL Financial Services's 13F filing for Q4 2017, filed 1 Feb 2018.